InsiderTrades.com logo
Viviane Monges net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Viviane Monges Biography and Net Worth

Director of Pharvaris

Ms. Monges has been a director since July 2021 and serves as the Chair of the Audit Committee. She serves as a non-executive director at Ferring Pharmaceuticals, ADC Therapeutics, BioMerieux and Novo Holdings. Prior to these roles, Ms. Monges was Chair of the board of EUROAPI, she held a position as VP of Finance of Nestlé’s Business Excellence Division. Prior to that, she served as the Global CFO of the OTC division at Novartis. Ms. Monges also served as CFO of European Pharmaceuticals at Wyeth/Pfizer and as CFO of the Global Pharmaceutical Business unit of Wyeth/Pfizer. She holds an MBA from Ecole Supérieure de Commerce de Paris.

What is Viviane Monges' net worth?

The estimated net worth of Viviane Monges is at least $165.69 thousand as of May 21st, 2026. Monges owns 5,500 shares of Pharvaris stock worth more than $165,688 as of June 3rd. This net worth evaluation does not reflect any other investments that Monges may own. Learn More about Viviane Monges' net worth.

How do I contact Viviane Monges?

The corporate mailing address for Monges and other Pharvaris executives is , , . Pharvaris can also be reached via phone at 31-71-203-6410 and via email at [email protected]. Learn More on Viviane Monges' contact information.

Has Viviane Monges been buying or selling shares of Pharvaris?

During the past quarter, Viviane Monges has sold $292,813.43 in shares of Pharvaris stock. Most recently, Viviane Monges sold 9,667 shares of the business's stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $30.29, for a transaction totalling $292,813.43. Following the completion of the sale, the director now directly owns 5,500 shares of the company's stock, valued at $166,595. Learn More on Viviane Monges' trading history.

Who are Pharvaris' active insiders?

Pharvaris' insider roster includes Elisabeth Bjork (Director), Robert Glassman (Director), Anne Lesage (Chief Early Development Officer), Anne Lesage (Insider), Peng Lu (Chief Medical Officer), Berndt Modig (Chief Executive Officer, Director (CH)), Viviane Monges (Director), David Nassif (CFO), Anna Nijdam (Insider), and Wim Souverijns (Insider). Learn More on Pharvaris' active insiders.

Are insiders buying or selling shares of Pharvaris?

In the last twelve months, insiders at the sold shares 24 times. They sold a total of 209,948 shares worth more than $6,268,140.96. The most recent insider tranaction occured on May, 22nd when insider Anna Nijdam sold 5,501 shares worth more than $169,100.74. Learn More about insider trades at Pharvaris.

Information on this page was last updated on 5/22/2026.

Viviane Monges Insider Trading History at Pharvaris

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/21/2026Sell9,667$30.29$292,813.435,500View SEC Filing Icon  
See Full Table

Viviane Monges Buying and Selling Activity at Pharvaris

This chart shows Viviane Monges's buying and selling at Pharvaris by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pharvaris Company Overview

Pharvaris logo
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.
Read More

Today's Range

Now: $30.14
Low: $28.80
High: $30.50

50 Day Range

MA: $28.86
Low: $25.34
High: $32.94

2 Week Range

Now: $30.14
Low: $15.91
High: $33.33

Volume

703,962 shs

Average Volume

233,293 shs

Market Capitalization

$1.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A